Klaus Frueh
President at Tomegavax, Inc.
Profile
Klaus Frueh is the founder of Vir Biotechnology, Inc. which was founded in 2016.
He held the title of Director from 2016 to 2019.
Currently, Dr. Frueh is the President & Secretary at Tomegavax, Inc.
Klaus Frueh active positions
Companies | Position | Start |
---|---|---|
Tomegavax, Inc.
Tomegavax, Inc. Miscellaneous Commercial ServicesCommercial Services Tomegavax, Inc. provides health, science and drug services. It develops cures for AIDS, malaria, tuberculosis, herpes, papillomavirus and hepatitis-diseases where there’s no natural immunity in humans and traditional vaccine mechanisms don’t work. The company was founded in 2011 and is headquartered in Beaverton, OR. | President | - |
Former positions of Klaus Frueh
Companies | Position | End |
---|---|---|
VIR BIOTECHNOLOGY, INC. | Founder | 2019-10-15 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
VIR BIOTECHNOLOGY, INC. | Health Technology |
Private companies | 1 |
---|---|
Tomegavax, Inc.
Tomegavax, Inc. Miscellaneous Commercial ServicesCommercial Services Tomegavax, Inc. provides health, science and drug services. It develops cures for AIDS, malaria, tuberculosis, herpes, papillomavirus and hepatitis-diseases where there’s no natural immunity in humans and traditional vaccine mechanisms don’t work. The company was founded in 2011 and is headquartered in Beaverton, OR. | Commercial Services |
- Stock Market
- Insiders
- Klaus Frueh